Form 4: Spectral AI CEO Vincent Capone Increases Equity Stake
Statement of Changes in Beneficial Ownership
Spectral AI CEO Vincent S. Capone acquired 16,750 shares of common stock at an average price of $1.52 per share.
Summary
- CEO Vincent S. Capone purchased 16,750 shares of Spectral AI (MDAI) common stock on March 27, 2026.
- The shares were acquired at a weighted average price of $1.52 per share.
- Following this transaction, the CEO's total direct beneficial ownership increased to 186,450 shares of common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as CEO open-market purchases typically indicate internal confidence in the company's future prospects.
Positives
- Insider confidence is demonstrated by the CEO increasing his personal equity stake in the company.
- The purchase was made at a price point of $1.52, signaling management's belief in the current valuation.
Negatives
- NA
Risks
- The company remains subject to market volatility and the inherent risks associated with the medical technology sector.
- Future vesting of derivative securities is contingent upon performance milestones, which may not be met.
Future Outlook
The filing does not provide forward-looking financial guidance, but notes that certain stock options are subject to future vesting based on the achievement of specific company milestones.
Management Comments
- The reporting person has committed to providing full information regarding the number of shares purchased at each separate price within the reported range upon request.
Industry Context
StockSavvy.ai notes that insider buying, particularly by a CEO, is generally viewed as a positive signal of management's alignment with shareholder interests and confidence in the company's long-term strategic direction.
Comparison to Industry Standards
- Insider buying activity is consistent with standard corporate governance practices where executives maintain significant 'skin in the game' to align with investor outcomes.
- The purchase price of $1.52 reflects the current market valuation of small-cap medical technology firms in the diagnostic imaging space.
Legal Proceedings
- None mentioned.
Related Party Transactions
- None mentioned.
Stakeholder Impact
- Shareholders may interpret this purchase as a sign of stability and management commitment to the company's growth.
Next Steps
- Continued monitoring of insider transaction filings for further changes in equity positions.
- Tracking of performance milestones related to the vesting of outstanding derivative securities.
Key Dates
| Date | Description |
|---|---|
| 03/27/2026 | Date of the reported stock purchase transaction. |
| 04/06/2026 | Date the Form 4 was signed and filed. |
Keywords
Spectral AI, MDAI, Insider Trading, Form 4, Vincent Capone, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.